Wilmington, DE, United States of America

Alexei Prokhnevsky

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexei Prokhnevsky: Innovator in Virus-Like Particle Technology

Introduction

Alexei Prokhnevsky is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of biotechnology, particularly in the development of virus-like particles (VLPs). His innovative work has the potential to impact various therapeutic applications.

Latest Patents

Prokhnevsky holds 1 patent for his invention titled "Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof." This patent describes novel VLPs that incorporate a matrix protein derived from a plant enveloped virus along with a surface polypeptide. The surface polypeptide consists of a surface exposed portion derived from a target polypeptide, a transmembrane domain, and a cytosolic tail derived from a transmembrane protein of a second plant enveloped virus. The invention highlights the potential use of these VLPs in antigenic or therapeutic applications.

Career Highlights

Alexei Prokhnevsky is currently associated with Fraunhofer USA, Inc., where he continues to advance his research in biotechnology. His work focuses on the intersection of plant biology and virology, aiming to harness the unique properties of plant viruses for innovative applications.

Collaborations

Prokhnevsky collaborates with esteemed colleagues in his field, including Vidadi Yusibov and Vadim Mett. These collaborations enhance the research and development of VLP technologies, fostering innovation and scientific advancement.

Conclusion

Alexei Prokhnevsky's contributions to the field of virus-like particles exemplify the potential of biotechnology to address complex challenges in medicine. His innovative work continues to pave the way for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…